These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2150077)
21. Neuropsychological and neuroradiological study of a case of early-onset Huntington's chorea. Lenti C; Bianchini E Dev Med Child Neurol; 1993 Nov; 35(11):1007-10. PubMed ID: 8224553 [TBL] [Abstract][Full Text] [Related]
22. [The CT image of atrophy of the head of the caudate nucleus in Huntington's chorea]. Roth J; Havrdová E; Stiková V; Bauer J Cas Lek Cesk; 1996 May; 135(9):277-9. PubMed ID: 8706085 [TBL] [Abstract][Full Text] [Related]
23. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study. Turjanski N; Weeks R; Dolan R; Harding AE; Brooks DJ Brain; 1995 Jun; 118 ( Pt 3)():689-96. PubMed ID: 7600086 [TBL] [Abstract][Full Text] [Related]
24. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease. Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME Arch Neurol; 1992 Nov; 49(11):1161-7. PubMed ID: 1444883 [TBL] [Abstract][Full Text] [Related]
25. The scintigraphic evaluation of Huntington's disease and other movement disorders using single photon emission computed tomography perfusion brain scans. Nagel JS; Ichise M; Holman BL Semin Nucl Med; 1991 Jan; 21(1):11-23. PubMed ID: 1825359 [TBL] [Abstract][Full Text] [Related]
26. Single photon emission computerized tomography (SPECT) in detecting neurodegeneration in Huntington's disease. Reynolds NC; Hellman RS; Tikofsky RS; Prost RW; Mark LP; Elejalde BR; Lebel R; Hamsher KS; Swanson S; Benezra EE Nucl Med Commun; 2002 Jan; 23(1):13-8. PubMed ID: 11748433 [TBL] [Abstract][Full Text] [Related]
27. Computed tomography for Huntington's disease. Terrence CF; Delaney JF; Alberts MC Neuroradiology; 1977 Jun; 13(4):173-5. PubMed ID: 141627 [TBL] [Abstract][Full Text] [Related]
28. Normal caudate glucose metabolism in persons at risk for Huntington's disease. Young AB; Penney JB; Starosta-Rubinstein S; Markel D; Berent S; Rothley J; Betley A; Hichwa R Arch Neurol; 1987 Mar; 44(3):254-7. PubMed ID: 2950844 [TBL] [Abstract][Full Text] [Related]
29. [Comparison of D2 receptor scintigraphy (123I-IBZM) with cerebral perfusion (99m-Tc-HMPAO) in extrapyramidal disorders]. Saur HB; Bartenstein P; Schober O; Oberwittler C; Lerch H; Masur H Nuklearmedizin; 1994 Oct; 33(5):184-8. PubMed ID: 7997375 [TBL] [Abstract][Full Text] [Related]
30. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. Mazziotta JC; Phelps ME; Pahl JJ; Huang SC; Baxter LR; Riege WH; Hoffman JM; Kuhl DE; Lanto AB; Wapenski JA N Engl J Med; 1987 Feb; 316(7):357-62. PubMed ID: 2949152 [TBL] [Abstract][Full Text] [Related]